| 61/170 | US=73 / Biol/Mol Korenberg MJ, Farinha P, Gascoyne RD. Predicting survival in follicular lymphoma using tissue microarrays. In: Korenberg MJ. Microarray data analysis: methods and applications. New Jersey: Humana Press, 2007. p. 255-68. (Methods in molecular biology, v.377) ISBN 978-1-58829-540-8. LINFOMA FOLICULAR; SOBREVIDA; MICROARRAYS DE TECIDOS; BIOMARCADORES |
| 62/170 | US=84 / Câncer Hamdan MH. Overview. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 1-20. ISBN 978-0-471-74516-7. BIOMARCADORES DE CANCER; FASES DE DESENVOLVIMENTO DE BIOMARCADORES |
| 63/170 | US=84 / Câncer Hamdan MH. Some existing cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 113-62. ISBN 978-0-471-74516-7. BIOMARCADORES DE CANCER; DESSORCAO DE IONIZACAO; BIOINFORMATICA EM SELDI; MICRODISSECTION CAPTURA A LASER; PRETEIN MICRORRAYS; CROMATOGRAFIA LIQUIDA MULTIDIMENSIONAL |
| 64/170 | US=84 / Câncer Hamdan MH. Potential cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 163-248. ISBN 978-0-471-74516-7. POTENCIAIS BIOMARCADORES DE CANCER; CALICREINAS DE TECIDO HUMANO; FAMILIA DE PROTEINAS; PROTEINAS DE LIGACAO DE CALCIO |
| 65/170 | US=84 / Câncer Hamdan MH. Ethical issues and initiatives relevant to cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 321-61. ISBN 978-0-471-74516-7. |
| 66/170 | US=2 / Mama Simon RM. General topics: guidelines for the design of clinical studies for the development and validation of therapeutically relevant biomarkers and biomarker-based classification systems. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 1-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; MICROARRAYS; SISTEMA DE CLASSIFICACAO; ENSAIOS CLINICOS |
| 67/170 | US=2 / Mama Sweep FCGJ, Thomas CMG, Schmitt M. General topics: analytical aspects of biomarker immunoassays in cancer research. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 17-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; IMUNOENSAIOS; MARCADORES TUMORAIS |
| 68/170 | US=2 / Mama Kim C, Paik S. General topics: tissue microarrays: state of the art, pitfalls, and promises. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 31-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; TISSUE MICROARRAYS; ENSAIOS CLINICOS MULTICENTRICOS; TISSUE ARRAY |
| 69/170 | US=2 / Mama Daidone MG, Silvestrini R, Amadori D. Tissue predictive biomakers: cell kinetics. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 81-109. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES DE TECIDO PREDITIVOS; CINETICA CELULAR; PADRONIZACAO DO ENSAIO; ENSAIOS CLINICOS; VARIACOES POS-TRATAMENTO |
| 70/170 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA |
| 71/170 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 129-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; VALOR PREDITIVO DE C-ERB-B2; HORMONIOTERAPIA; QUIMIOTERAPIA; CANCER DE MAMA; TRASTUZUMABE |
| 72/170 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 73/170 | US=2 / Mama Kandioler D, Jakesk R. Tissue predictive biomakers: p53 as a prognostic and predicitive indicator. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 193-209. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |
| 74/170 | US=2 / Mama Braun S, Seeber J, Marth C. Predictive biomarkers in body fluids: occult metastatic cells in breast cancer patients. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 213-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CELULAS METASTATICAS; CANCER DE MAMA; PROGNOSTICO |
| 75/170 | US=2 / Mama Lipton A, Demmers L, Leitzel K, Ali SM, Neumann R, Price CP, Carney WP. Predictive biomarkers in body fluids: circulating HER2/neu: clinical utility. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 235-65. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO HER2/NEU; ONCOPROTEINA; CANCER DE MAMA |
| 76/170 | US=2 / Mama Sarmiento R, Franceschini R, Meo S, Gion M, Longo R, Gaspirini G. Predictive biomarkers in body fluids: circulating vascular endothelial growth factor. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 267-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; CANCER DE MAMA; ANGIOGENESE; TERAPIA; PROGNOSTICO |
| 77/170 | US=2 / Mama Hawes D, Cote RJ. Predictive biomarkers in body fluids: detection of early tumor dissemination in patients with breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 293-321. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; DETECCAO DE DISSEMINACAO DO TUMOR PRECOCE; CANCER DE MAMA; MEDULA OSSEA; CELULAS TUMORAIS CIRCULANTES; DISSEMINACAO DO TUMOR NO INICIO; CITOMETRIA DE FLUXO; IMUNO-HISTOQUIMICA; SEPARACAO IMUNO-MAGNETICA; LINFONODOS; MICROMETASTASES; METASTASES OCULTAS; SANGUE PERIFERICO; REACAO REVERSA DA CADEIA DE TRANSCRIPTASE-POLIMERASE; LINFONODO SENTINELA |
| 78/170 | US=2 / Mama Hawes D, Cote RJ. Future directions: new technologies/new markers/new challenges. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 325-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |
| 79/170 | US=20 / Biol/Mol Smiley S, Wong MKK, Mousa SA. Methods for monitoring of the anti-angiogenic activity of agents in patients: novel trial design. In: Staton CA, Lewis C, Bicknell R. Angiogenesis assays: a critical appraisal of current techniques. New Jersey: John Wiley & Sons, 2006. p. 341-59. ISBN 978-0-470-01600-8. METODOS DE MONITORAMENTO DA ATIVIDADE ANTI-ANGIOGENICA; ANGIOGENESE; ENSAIOS CLINICOS; CANCER; DISTURBIOS VASCULARES; IMAGEM; BIOMARCADORES; TERAPIA ADJUNTA |
| 80/170 | US=2-A / Biol/Mol Bhojani MS, Laxman B, Ross BD, Rehemtulla A. Molecular diagnosis: molecular imaging in cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 703-27. ISBN 978-3-527-31237-5. DIAGNOSTICO MOLECULAR; IMAGIOLOGIA MOLECULAR; CANCER; IMAGEM OPTICO; IMAGEM DE BIOLUMINESCENCIA; IMAGEM FLUORESCENTE; RESSONANCIA MAGNETICA; IMAGEM NUCLEAR; IMAGEM MULTIMODAL; BIOMARCADORES; P53; METASTASE; ANGIOGENESE |